Answer
Patients receiving daunorubicin combination therapy should not drive or use machines if they experience confusion, seizures or visual disturbances during treatment.
Sources for this answer
- Daunorubicin 20mg Powder for InjectionZentiva · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 7Document updated
Sources checked